Suggestions
Kevin Xie
Head, Global Strategic Business Development at Boehringer Ingelheim
Kevin Xie is a highly qualified professional with a diverse educational background and significant experience in both molecular biology and business development.
He holds a Doctor of Philosophy (Ph.D.) in Molecular Biology from Yale University, demonstrating a deep understanding of advanced scientific concepts and research methodologies.
In addition to his science expertise, Kevin also pursued a Master of Business Administration (MBA) at Yale School of Management, equipping him with the necessary skills to navigate the business landscape effectively.
Prior to his current role, Kevin earned his B.S. in Genetics from Fudan University, showcasing his strong foundation in biological sciences.
Currently, Kevin Xie serves as the Head of Global Strategic Business Development at Boehringer Ingelheim, where he applies his scientific knowledge and business acumen to drive strategic initiatives and foster growth for the organization.
Kevin's unique combination of scientific expertise and business acumen makes him a valuable asset in the corporate world, allowing him to bridge the gap between cutting-edge research and strategic business development.
